Evidence that AI-fueled drug discovery is the way forward is hard to find now, but that could change in 2025. After merging with Exscientia, Recursion will have 10 clinical readouts to look forward to ...
Nvidia said it would invest $50 million in the company as it works to use AI for drug discovery. The surge in Recursion added more than $1 billion to its market valuation on Wednesday. Shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results